0000000000292853

AUTHOR

Beate Bartés

showing 2 related works from this author

Congenital hypothyroidism: A 2020-2021 consensus guidelines update-An ENDO-European Reference Network initiative endorsed by the European Society for…

2021

Background: An ENDO-European Reference Network (ERN) initiative was launched that was endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology with 22 participants from the ENDO-ERN and the two societies. The aim was to update the practice guidelines for the diagnosis and management of congenital hypothyroidism (CH). A systematic literature search was conducted to identify key articles on neonatal screening, diagnosis, and management of primary and central CH. The evidence-based guidelines were graded with the Grading of Recommendations, Assessment, Development and Evaluation system, describing both the strength of recommendations and the quali…

Transition to Adult Caremedicine.medical_specialtyConsensusdyshormonogenesisPediatric endocrinologyEndocrinology Diabetes and MetabolismLevothyroxine030209 endocrinology & metabolismHarmonization03 medical and health sciences0302 clinical medicineEndocrinologyNeonatal ScreeningPredictive Value of TestsRisk FactorsInternal medicineEpidemiologyCentral hypothyroidismneonatal screeningHumansMedicineguidelinesGrading (education)thyroid dysgenesisCongenital hypothyroidism guidelines pediatric endocrinologycongenital hypothyroifidm consensus guideline EndoERNEvidence-Based Medicinebusiness.industryInfant Newborncentral hypothyroidismcongenital hypothyroidismPrognosismedicine.diseaseCongenital hypothyroidismBenchmarkingEndocrinology030220 oncology & carcinogenesisFamily medicineEtiologySpecial Articlesbusinessmedicine.drugYearbook of Paediatric Endocrinology
researchProduct

Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement

2015

Graves' orbitopathy (GO) is a disfiguring autoimmune condition, which can sometimes cause blindness (1). The disease has profound effects on quality of life (2), psychological health (3), and socioeconomic status (4). Progress in understanding and treating this disease has been slow. However, recent advances include delineation of plausible immunological mechanisms (5), development of an animal model (6), and publication of randomized studies defining the role and limitations of intravenous steroids (7), rituximab (8,9), and selenium (10). Yet, some of this knowledge remains to be translated into improvement in clinical care. Access of patients to specialist treatments is patchy and seems t…

Research designmedicine.medical_specialtyPathologyClinical Trials as Topicbusiness.industryEndocrinology Diabetes and MetabolismResearchAlternative medicineDeclarationMEDLINEDiseasemedicine.diseaseGraves' ophthalmopathyGraves OphthalmopathyEndocrinologyQuality of life (healthcare)Research DesignmedicineHumansPatient participationPatient ParticipationIntensive care medicinebusinessEditorial and Commentary
researchProduct